基本信息
浏览量:5
职业迁徙
个人简介
Research Interest
Steroid biosynthesis, metabolism and actions
Professional Licenser
Licenser for practicing medicine (Japan, 1982 - )
Licenser for practicing medicine (U.S.A. State of Pennsylvania,1989 - )
American Board of Pathology, anatomic pathology (1989 - )
Japanese Board of Pathology (1990 - )
Japanese Board of Cytology (1991 - )
研究兴趣
论文共 1677 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Yohsuke Ohkubo,Masanori Yamazaki, Yasuho Shimada,Satoshi Kubota, Shohei Takayama,Ako Oiwa, Yuta Yamazaki,Hironobu Sasano,Mitsuhisa Komatsu
Shiko Honma, Naomi Sato, Ryoko Sakaguchi,Akinori Hashiguchi, Noriko Uesugi,Yasuhiro Nakamura,Hironobu Sasano,Kensuke Joh
Medical Molecular Morphologyno. 1 (2024): 23-34
Yoshikiyo Ono,Yuta Tezuka,Kei Omata,Ryo Morimoto,Yuto Yamazaki,Sota Oguro,Kei Takase,Akihiro Ito, Tatsunari Yoshimi, Satoshi Kojima,Sadayoshi Ito,Hironobu Sasano,
Journal of the Endocrine Society (2024)
FRONTIERS IN ENDOCRINOLOGY (2024): 1286297-1286297
Sherene Loi, Stephen Johnston,Carlos Arteaga,Stephanie Graff, Sarat Chandarlapaty,Matthew Goetz,Christine Desmedt,Jorge Reis-Filho,Hironobu Sasano, Vanessa Rodrik-Outmezguine, Anthony Sireci, Cynthia Sandoval Rubenstein,
Cancer Researchno. 9_Supplement (2024): PS06-01
Hypertension Researchno. 5 (2024): 1-10
Nicholas Turner,Jorge Reis-Filho,Matthew Goetz,Christine Desmedt, Sarat Chandarlapaty,Hironobu Sasano,Carlos Arteaga,Sherene Loi,Stephanie Graff, Deli Liu,Vanessa Rodrik-Outmezguine, Anthony Sireci,
Cancer Researchno. 9_Supplement (2024): GS03-06
Yoshikiyo Ono,Yuta Tezuka,Kei Omata,Ryo Morimoto,Yuto Yamazaki,Sota Oguro,Kei Takase,Akihiro Ito, Tatsunari Yoshimi, Satoshi Kojima,Sadayoshi Ito,Hironobu Sasano,
Journal of the Endocrine Societyno. 6 (2024): bvae080-bvae080
Richard J. Santen, Gulay Karaguzel,Murat Livaoglu,Wei Yue,J. Mark Cline,Aakrosh Ratan,Hironobu Sasano
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2024)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn